| Literature DB >> 26241032 |
Mei-Jung Lai1, Hsueh-Yun Lee2, Hsun-Yueh Chuang2, Li-Hsun Chang3, An-Chi Tsai4, Mei-Chuan Chen5, Han-Lin Huang4, Yi-Wen Wu6, Che-Ming Teng3, Shiow-Lin Pan4,6, Yi-Min Liu2, Samir Mehndiratta2, Jing-Ping Liou2,7.
Abstract
A series of N-sulfonyl-aminobiaryl derivatives have been examined as novel antitubulin agents. Compound 21 [N-(4'-cyano-3'-fluoro-biphenyl-2-yl)-4-methoxy-benzenesulfonamide] exhibits remarkable antiproliferative activity against four cancer cell lines (pancreatic AsPC-1, lung A549, liver Hep3B, and prostate PC-3) with a mean GI50 value of 57.5 nM. Additional assays reveal that 21 inhibits not only tubulin polymerization but also the phosphorylation of STAT3 inhibition with an IC50 value of 0.2 μM. Four additional compounds (8, 10, 19, and 35) are also able to inhibit this phosphorylation. This study describes novel N-sulfonyl-aminobiaryl (biaryl-benzenesulfonamides) as potent anticancer agents targeting both STAT3 and tubulin.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26241032 DOI: 10.1021/acs.jmedchem.5b00659
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446